Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars
Launched by ALEXANDRIA UNIVERSITY · Aug 20, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of treating scars that result from burns or injuries. The researchers want to find out whether using a method called autologous nanofat injection (which involves using fat taken from the patient's own body) is more effective than using microneedling to deliver the same fat. Both methods aim to help improve the appearance of these scars.
To be eligible for this study, you need to be between 18 and 60 years old and have scars from burns or injuries that have been present for more than six months. It's important that you haven’t received any treatments for these scars in the past three months. The trial is open to both men and women. If you decide to participate, you can expect to receive one of the two treatments and be monitored for how well it works in improving your scars. Remember, this study does not include individuals with certain conditions, like specific types of scars or serious health issues, so make sure to discuss your eligibility with the research team.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Males and females between 18-60 years old. 2. Post-burn or traumatic atrophic scar \> 6 months duration (16). 3. Patients not receiving any treatments for the scar within the past 3 months.
- Exclusion Criteria:
- • 1. Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy.
- • 3. Diabetes and other systemic diseases that may be complicated by the procedure.
- • 4. Pregnant and lactating females. 5. BMI less than 18.5 6. Patients with scars at the donor site
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported